Your browser is no longer supported. Please, upgrade your browser.
LCI Lannett Company, Inc. daily Stock Chart
Lannett Company, Inc.
Index- P/E9.45 EPS (ttm)1.76 Insider Own11.60% Shs Outstand37.17M Perf Week1.22%
Market Cap617.02M Forward P/E5.89 EPS next Y2.82 Insider Trans-3.14% Shs Float29.27M Perf Month1.84%
Income66.60M PEG- EPS next Q0.78 Inst Own- Short Float51.86% Perf Quarter-39.64%
Sales644.10M P/S0.96 EPS this Y-101.30% Inst Trans6.03% Short Ratio21.69 Perf Half Y0.30%
Book/sh15.99 P/B1.04 EPS next Y-11.04% ROA2.90% Target Price25.00 Perf Year-20.19%
Cash/sh4.51 P/C3.68 EPS next 5Y-3.62% ROE8.40% 52W Range14.90 - 30.35 Perf YTD-28.45%
Dividend- P/FCF3.19 EPS past 5Y-16.10% ROI5.80% 52W High-45.30% Beta2.55
Dividend %- Quick Ratio1.80 Sales past 5Y39.00% Gross Margin45.10% 52W Low11.41% ATR0.72
Employees1126 Current Ratio2.30 Sales Q/Q7.80% Oper. Margin24.90% RSI (14)40.48 Volatility3.85% 4.40%
OptionableYes Debt/Eq1.49 EPS Q/Q294.00% Profit Margin7.40% Rel Volume1.34 Prev Close16.20
ShortableYes LT Debt/Eq1.38 EarningsFeb 07 AMC Payout0.00% Avg Volume699.99K Price16.60
Recom2.50 SMA201.36% SMA50-14.34% SMA200-19.99% Volume937,286 Change2.47%
Jan-24-18Initiated Goldman Neutral
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Sep-11-13Reiterated Oppenheimer Outperform $15 → $20
May-23-13Initiated Needham Buy $15
Feb-08-13Reiterated Oppenheimer Outperform $6 → $9
Mar-16-18 09:40AM  Is Lannett Company (LCI) a Great Stock for Value Investors? Zacks
Mar-12-18 09:01AM  Hat trick: Lannett enters into 3 product agreements American City Business Journals
06:54AM  Lannett Adds New Revenue Streams, Announces Agreements With Three Strategic Alliance Partners PR Newswire
Mar-09-18 07:00AM  Free Post Earnings Research Report: Lannett's Quarterly Earnings Advanced 15.22% ACCESSWIRE
Feb-27-18 06:52AM  Lannett To Participate At Three Investor Conferences In March PR Newswire
Feb-18-18 02:10PM  Edited Transcript of LCI earnings conference call or presentation 7-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-15-18 08:25AM  Investor Expectations to Drive Momentum within Workday, The Medicines, Celldex Therapeutics, Lannett, Oclaro, and Antares Pharma Discovering Underlying Factors of Influence GlobeNewswire
Feb-08-18 04:31PM  Why Lannett Company, Inc. Is Falling Today Motley Fool -11.52%
Feb-07-18 07:01PM  Lannett beats 2Q profit forecasts Associated Press
04:15PM  Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings PR Newswire
06:54AM  Lannett Voluntarily Pays Down $25 Million Of Term Loans PR Newswire
Feb-01-18 06:54AM  Lannett Enters Into Consulting Agreement With Former CEO, Arthur Bedrosian PR Newswire
Jan-31-18 06:53AM  Lannett To Report Fiscal 2018 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 7 PR Newswire -6.00%
Jan-30-18 08:41AM  What Does Lannett Company Incs (NYSE:LCI) Share Price Indicate? Simply Wall St.
Jan-18-18 06:53AM  Lannett Names Timothy C. Crew To Board Of Directors PR Newswire
Jan-11-18 03:00AM  Stocks Showing Improved Relative Strength: Lannett Investor's Business Daily
Jan-05-18 09:00AM  Haeggquist & Eck Investigates Breach of Fiduciary Duties by Lannett Officers and Directors Related to Criminal Investigation into Potential Price Collusion Business Wire
Jan-04-18 03:00AM  Stocks Generating Improved Relative Strength: Lannett Investor's Business Daily
Dec-26-17 11:44AM  ETFs with exposure to Lannett Co., Inc. : December 26, 2017 Capital Cube
Dec-25-17 09:35AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q1, 2018 By the Numbers : December 25, 2017 Capital Cube
Dec-22-17 07:35AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : December 22, 2017 Capital Cube
Dec-21-17 09:00AM  Lannett names new CEO American City Business Journals -6.23%
06:54AM  Lannett Appoints Timothy C. Crew As CEO PR Newswire
Dec-19-17 07:00AM  Free Post Earnings Research Report: Lannett Co.s Revenue Grew 4.1% ACCESSWIRE
Dec-13-17 02:44PM  Is Lannett Company Incs (NYSE:LCI) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Dec-12-17 03:25PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Lannett Company, Inc. (LCI) on Behalf of Shareholders Business Wire
Dec-11-17 12:54PM  Lannett To Participate At Two Investment Conferences In December PR Newswire
Dec-04-17 03:00AM  Lannett Shows Market Leadership With Jump To 94 RS Rating Investor's Business Daily
Dec-01-17 01:17PM  Lannett shares jump 8% on news it will be exclusive distributor of beta-blocker Toprol-XL MarketWatch +8.51%
08:30AM  Report: Exploring Fundamental Drivers Behind Lannett, Oclaro, Antares Pharma, Workday, The Medicines, and Celldex Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
06:53AM  Lannett Announces FDA Acceptance Of 505(b)(2) New Drug Application For Cocaine Hydrochloride Topical Solution, A Proprietary Anesthetic Product PR Newswire
Nov-29-17 04:47PM  Lannett Announces Agreement For Authorized Generic Version Of Toprol-XL® PR Newswire
Nov-28-17 11:41AM  Scott+Scott, Attorneys at Law, LLP is Investigating Derivative Claims on Behalf of Shareholders of Lannett Company, Inc. Business Wire
Nov-20-17 04:55PM  Is It Time To Buy Lannett Company Inc (LCI) Based Off Its PE Ratio? Simply Wall St.
Nov-09-17 12:05PM  Scott+Scott, Attorneys at Law, LLP is Investigating Derivative Claims on Behalf of Shareholders of Lannett Company, Inc. (LCI) PR Newswire
06:56AM  Lannett To Present At The Jefferies 2017 London Healthcare Conference On November 15 PR Newswire
Nov-08-17 08:51PM  Edited Transcript of LCI earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
03:00AM  Lannett Joins Elite Club Of Stocks With RS Ratings Over 90 Investor's Business Daily
Nov-06-17 06:45PM  Lannett beats Street 1Q forecasts Associated Press
04:15PM  Lannett Reports Solid Fiscal 2018 First-Quarter Financial Results, Significantly Increases Fiscal 2018 Guidance PR Newswire
Nov-01-17 06:53AM  Lannett Comments On Amended Civil Complaint PR Newswire +8.29%
Oct-31-17 01:04PM  Connecticut AG on drug pricing suit: Breadth of alleged c... CNBC Videos -13.67%
11:59AM  Today's charts: Under Armour sinks; Mylan drops on drug-pricing probe; Mondelez 3Q profit soars 81% Yahoo Finance
08:15AM  New Research Coverage Highlights Annaly, Praxair, Tailored Brands, Lannett, Legg Mason, and AutoNation Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-30-17 12:01PM  ETFs with exposure to Lannett Co., Inc. : October 30, 2017 Capital Cube
10:40AM  Lannett works out a deal with Celgene American City Business Journals
06:52AM  Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid® PR Newswire
Oct-26-17 06:51AM  Lannett To Report Fiscal 2018 First-Quarter Financial Results, Host Conference Call On Monday, November 6 PR Newswire
Oct-20-17 10:17AM  ETFs with exposure to Lannett Co., Inc. : October 20, 2017 Capital Cube
Oct-09-17 11:44AM  ETFs with exposure to Lannett Co., Inc. : October 9, 2017 Capital Cube
Oct-06-17 09:11AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q4, 2017 By the Numbers : October 6, 2017 Capital Cube
Oct-02-17 01:52PM  Lannett Company Inc (LCI): What Does It Mean For Your Portfolio? Simply Wall St. +11.11%
06:56AM  Lannett Receives Two FDA Approvals For Lansoprazole Delayed-Release Capsules USP, One Each For Full Prescription And OTC PR Newswire
Sep-29-17 07:50AM  Corporate News Blog - Lannett Gets FDA Approval for Oxycodone and Acetaminophen Tablets USP ACCESSWIRE
Sep-28-17 10:15AM  ETFs with exposure to Lannett Co., Inc. : September 28, 2017 Capital Cube
08:16AM  Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : September 28, 2017 Capital Cube
Sep-27-17 06:51AM  Lannett Receives FDA Approval For Oxycodone And Acetaminophen Tablets USP, 5 mg/325 mg And 10 mg/325 mg PR Newswire +8.76%
Sep-26-17 06:53AM  Lannett Receives Approval For Dexmethylphenidate Hydrochloride Tablets, 2.5 mg, 5 mg And 10 mg PR Newswire
06:40AM  Lannett Announces Dismissal Of Class Action Lawsuit PR Newswire
Sep-25-17 06:54AM  Lannett's Board Of Directors Initiates CEO Search PR Newswire
Sep-22-17 06:53AM  Arthur Bedrosian, Lannett CEO, Prevails In Lawsuit With Internal Revenue Service PR Newswire
Sep-13-17 07:00AM  Earnings Review and Free Research Report: Lannetts Sales and Earnings Results Met Expectations ACCESSWIRE
Sep-06-17 05:02PM  What Is Lannett Company Incs (LCI) Share Price Doing? Simply Wall St.
Sep-05-17 03:30PM  Lannett receives FDA OK for generic Nexium product American City Business Journals
09:45AM  Lannett Scores FDA OK for Nexium Generic-Biotech Movers
06:53AM  Lannett Receives Approval For Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg And 40 mg PR Newswire
Sep-01-17 08:10PM  ETFs with exposure to Lannett Co., Inc. : September 2, 2017 Capital Cube
Aug-30-17 01:30PM  Lannett Co., Inc. :LCI-US: Earnings Analysis: 2017 By the Numbers : August 30, 2017 Capital Cube
Aug-24-17 08:26PM  Edited Transcript of LCI earnings conference call or presentation 23-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
10:57AM  Lannett (LCI) Q4 Earnings In Line, Stock Up on Solid View Zacks
Aug-23-17 09:46PM  Lannett posts 4Q profit Associated Press
04:24PM  Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018 PR Newswire
10:00AM  Investor Network: Lannett Company, Inc. to Host Earnings Call ACCESSWIRE
Aug-15-17 06:06PM  Lannett Co., Inc. Value Analysis (NYSE:LCI) : August 15, 2017 Capital Cube
Aug-08-17 06:54AM  Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook PR Newswire
Aug-07-17 04:21PM  3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping? Motley Fool
Aug-05-17 08:27AM  Teva, Mylan Seen to Stay on M&A Sidelines
Aug-03-17 07:02AM  Take a Look at 5 Stocks with Attractive Price-to-Book Ratio Zacks -8.00%
Aug-02-17 11:29AM featured highlights: Vishay Intertechnology, Big Lots, Applied Materials and Lannett Company Zacks -6.95%
09:14AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : August 2, 2017 Capital Cube
Aug-01-17 08:08AM  4 Low Price-to-Cash-Flow Stocks for Assured Returns Zacks
06:53AM  Lannett To Present At The Canaccord Genuity 37th Annual Growth Conference On August 9 PR Newswire
Jul-24-17 04:57PM  ETFs with exposure to Lannett Co., Inc. : July 24, 2017 Capital Cube
Jul-17-17 09:01AM  Fox Rothschild partner becomes general counsel of local drug manufacturer American City Business Journals
07:20AM  Corporate News Blog - Lannett Co. Receives Approval for Cyproheptadine Hydrochloride Syrup Accesswire
06:53AM  Lannett Appoints Samuel H. Israel As General Counsel PR Newswire
Jul-14-17 06:53AM  Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL PR Newswire +6.57%
Jul-12-17 02:46PM  ETFs with exposure to Lannett Co., Inc. : July 12, 2017 Capital Cube
Jul-04-17 08:57AM  Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : July 4, 2017 Capital Cube
Jun-28-17 08:15AM  Corporate News Blog - Lannett Receives Approval for Additional Dosage Strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP Accesswire
Jun-26-17 06:51AM  Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP PR Newswire
Jun-22-17 06:53AM  Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg PR Newswire
Jun-20-17 06:52AM  Lannett Names Patrick G. LePore To Board of Directors PR Newswire
Jun-19-17 03:38PM  ETFs with exposure to Lannett Co., Inc. : June 19, 2017 Capital Cube
08:15AM  Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season Accesswire
06:53AM  Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg PR Newswire
Jun-16-17 11:49AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
06:53AM  Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg PR Newswire
May-26-17 06:53AM  Lannett Company's Chief Executive Officer Receives High Rating PR Newswire
May-16-17 06:52AM  Lannett Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL) PR Newswire
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout. In addition, the company manufactures active pharmaceutical ingredients; and markets its products under the Diamox, Lipitor, Lioresal, Fioricet, Fiorinal, Lanoxin, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Imitrex, Brethine, Tussionex, and Actigall brands. Further, it sells pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FARBER DAVID10% OwnerJan 09Sale25.0110,000250,1004,171,269Jan 10 04:39 PM
FARBER DAVID10% OwnerDec 13Sale30.001845,5204,181,269Dec 15 04:05 PM
FARBER DAVID10% OwnerDec 05Sale30.058,716261,9164,181,453Dec 06 04:24 PM
FARBER DAVID10% OwnerDec 04Sale30.011,10033,0114,190,169Dec 06 04:24 PM
FARBER DAVID10% OwnerDec 01Sale26.8810,000268,8004,191,269Dec 04 04:19 PM
BEDROSIAN ARTHUR PCEONov 27Sale27.4557815,866586,038Nov 27 04:13 PM
BEDROSIAN ARTHUR PCEONov 24Sale26.7550,0001,337,500586,616Nov 27 04:13 PM
BEDROSIAN ARTHUR PCEONov 22Sale25.5042,0001,071,000636,616Nov 27 04:13 PM
FARBER DAVID10% OwnerNov 08Sale25.039,800245,2944,201,269Nov 09 05:05 PM
BEDROSIAN ARTHUR PCEONov 08Sale25.207,422187,034679,001Nov 09 05:04 PM
FARBER DAVID10% OwnerNov 07Sale25.002005,0004,211,069Nov 09 05:05 PM